Dr. Li Zhang, MD
Claim this profileSun Yat-sen University Cancer Center
Expert in Non-Small Cell Lung Cancer
Studies Lung Cancer
20 reported clinical trials
28 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
MET positive
2Lung Cancer
Stage IV
Stage III
Progression
Affiliated Hospitals
Clinical Trials Li Zhang, MD is currently running
TROP2 ADC
for Cancer
A Phase I-II, First-in-Human Study of SKB264 in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard Therapies. Patient must have historically documented, incurable, locally advanced or metastatic cancer that are refractory to standard therapies of one of the following types: 1. Triple negative breast cancer 2. Epithelial ovarian cancer 3. Non-small cell lung cancer 4. Gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma 5. Small cell lung cancer 6. HR+/ HER2-breast cancer 7. Head and neck squamous cell carcinoma 8. Endometrial carcinoma 9. Urothelial carcinoma
Recruiting1 award Phase 1 & 213 criteria
Zenocutuzumab
for Non-Small Cell Lung and Prostate Cancers
This is a Phase II, open-label, 2-arm, multicenter, international study designed to evaluate the efficacy of zenocutuzumab alone or in combination in patients with the following diagnoses: Group A: NRG1+ NSCLC Group B: mCRPC
Recruiting1 award Phase 2
More about Li Zhang, MD
Clinical Trial Related2 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Li Zhang, MD has experience with
- Placebo
- Gefitinib
- Pemetrexed
- Carboplatin
- Bevacizumab
- HR20013 For Injection
Breakdown of trials Li Zhang, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Vomiting
- Study of HR20013 for Injection in Patients With Malignant Solid Tumors
- Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors
- Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Li Zhang, MD specialize in?
Li Zhang, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Li Zhang, MD currently recruiting for clinical trials?
Yes, Li Zhang, MD is currently recruiting for 3 clinical trials in Guangzhou Guangdong. If you're interested in participating, you should apply.
Are there any treatments that Li Zhang, MD has studied deeply?
Yes, Li Zhang, MD has studied treatments such as Placebo, Gefitinib, Pemetrexed.
What is the best way to schedule an appointment with Li Zhang, MD?
Apply for one of the trials that Li Zhang, MD is conducting.
What is the office address of Li Zhang, MD?
The office of Li Zhang, MD is located at: Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510006 China. This is the address for their practice at the Sun Yat-sen University Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.